Covered recipient · General Payments record
STEPHANIE M ROGERS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,944.91
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,760.00 | 1 |
| Travel and Lodging | $854.68 | 3 |
| Food and Beverage | $588.94 | 10 |
| Education | $198.95 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $2,833.58 | 8 |
| Janssen Biotech, Inc. | $370.02 | 6 |
| BeiGene USA, Inc. | $99.97 | 1 |
| Astellas Pharma US Inc | $99.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $99.00 | 07/12/2024 | Education | Undisputed | 01/23/2026 | 1139460688 | CMS |
| BeiGene USA, Inc. | $99.97 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120854413 | CMS |
| GENZYME CORPORATION | $24.11 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139894154 | CMS |
| GENZYME CORPORATION | $20.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139894156 | CMS |
| GENZYME CORPORATION | $397.06 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139894244 | CMS |
| GENZYME CORPORATION | $53.53 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139894246 | CMS |
| GENZYME CORPORATION | $149.60 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139894248 | CMS |
| GENZYME CORPORATION | $25.19 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139894250 | CMS |
| GENZYME CORPORATION | $404.09 | 11/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139894252 | CMS |
| GENZYME CORPORATION | $1,760.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139894254 | CMS |
| Janssen Biotech, Inc. | $20.46 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078270821 | CMS |
| Janssen Biotech, Inc. | $13.73 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078269511 | CMS |
| Janssen Biotech, Inc. | $99.95 | 06/26/2024 | Education | Undisputed | 01/23/2026 | 1078269897 | CMS |
| Janssen Biotech, Inc. | $96.46 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078269601 | CMS |
| Janssen Biotech, Inc. | $11.15 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078269861 | CMS |
| Janssen Biotech, Inc. | $128.27 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078269495 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.